Nov 21: 2 Strong Themes — Masks, Vaccines, Diagnostics & Epidemic Control

November 21, 2016 · #Masks #Vaccines, Diagnostics & Epidemic Control

2 strong themes — 1 running · 1 recurred. Top: Masks +12.6%.

Strong themes2 Top change+12.6% LeaderKM

Average change by strong theme

Average change of member stocks, by theme · descending
Masks
+12.6%
Vaccines, Diagnostics & Epidemic Control
+8.2%

Theme leaders · recent trend

The line is the trend; the end-point colour is the last trading day's direction. Stocks without enough price history show as -
ThemeLeaderChangeTrend
MasksKM+12.62%
Vaccines, Diagnostics & Epidemic ControlGeneOne Life Science+9.49%

Two health-related themes led the Korean market on Nov 21, 2016. Masks returned after a gap of 244 days, and vaccines and epidemic control stayed strong for a second straight day.

KM was the only stock in the Masks theme, rising 12.62% to close at 4668 on volume of 6949842 shares. A same-day Korean news report also pointed to the stock’s sharp gain during the session.

Vaccines, Diagnostics & Epidemic Control posted an average change of 8.18%, and both of its 2 stocks rose. GeneOne Life Science led with a gain of 9.49%, closing at 31275.

Today’s Strong Themes at a Glance

#ThemeStatusAvg. changeUp/TotalLeader
1Masksrecurred after 244 days+12.6%1/1KM
2Vaccines, Diagnostics & Epidemic Control2 days running+8.2%2/2GeneOne Life Science

Theme by Theme

1. Masks (recurred after 244 days)

StockChangeCloseLeader
KM 083550+12.6%4,668★

Related news

2. Vaccines, Diagnostics & Epidemic Control (2 days running)

StockChangeCloseLeader
GeneOne Life Science 011000+9.5%31,275★
Eagle Veterinary Technology 044960+6.9%7,000

Related news

Closing Thoughts

The vaccine theme’s streak stands at 2, in an episode that began on Nov 18. A Korean news report linked GeneOne Life Science to positive Phase 1 results for an avian influenza vaccine.

Eagle Veterinary Technology rose 6.87% on volume of 6870054 shares. Masks has lasted only one day so far, and the next session will show whether the theme continues.